EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.42
+2.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 118.15x
- P/S forward
- 0.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.68x
- Price / sales
- 0.62x
- Price / cash flow
- -3.78x
Enterprise value
- Enterprise value
- $516.2M
- EV / sales
- 0.64x
- EV / EBITDA
- -5.39x
- EV / EBIT
- -3.57x
- Market cap
- $504.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026